“Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP)” (2016) ADMET and DMPK, 4(4), pp. 302–313. doi:10.5599/admet.4.4.322.